Aeterna Zentaris Inc.

AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results.
PR Newswire; 11/11/2009; 2354 words; ...QUEBEC CITY, Nov. 11 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical...108 in ovarian cancer. Juergen Engel, Ph.D., AEterna Zentaris President and Chief Executive Officer, commented...

Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology.
PR Newswire; 11/11/2009; 1231 words; ...Keryx Biopharmaceuticals, Inc. today announced that data from...is in-licensed by Keryx from Aeterna Zentaris, Inc. (Nasdaq: AEZS; TSX: AEZ...About Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals is focused...

AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology.
PR Newswire; 11/11/2009; 1132 words; ...CITY, Nov. 11 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company...for the treatment of multiple myeloma. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a global biopharmaceutical company...

AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer.
PR Newswire; 11/9/2009; 991 words; ...CITY, Nov. 9 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ) (the "Company...for the treatment of multiple myeloma. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a global biopharmaceutical company...

AEterna Gains Positive Results In Phase III Trial Of Impavido.
BIOWORLD Today; 11/4/2009; 968 words; ...Germany-based Zentaris AG, a subsidiary of AEterna Laboratories Inc., of Quebec...results released by AEterna Tuesday involved...immune system). Zentaris intends to include...Jurgen Engel, Zentaris' managing director and AEterna's vice president...